Fiduciary Trust’s MetLife MET Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$309K Sell
4,372
-932
-18% -$69.8K ﹤0.01% 727
2025
Q4
$419K Sell
5,304
-752
-12% -$59.5K ﹤0.01% 618
2025
Q3
$499K Buy
6,056
+859
+17% +$67.6K 0.01% 560
2025
Q2
$418K Buy
5,197
+137
+3% +$10.6K 0.01% 576
2025
Q1
$406K Buy
5,060
+484
+11% +$40.3K 0.01% 569
2024
Q4
$375K Buy
4,576
+5
+0.1% +$416 ﹤0.01% 526
2024
Q3
$377K Sell
4,571
-631
-12% -$47.1K 0.01% 523
2024
Q2
$365K Buy
5,202
+36
+0.7% +$2.57K 0.01% 506
2024
Q1
$383K Sell
5,166
-1,304
-20% -$90.9K 0.01% 510
2023
Q4
$428K Sell
6,470
-725
-10% -$45.4K 0.01% 473
2023
Q3
$453K Sell
7,195
-1,409
-16% -$87.8K 0.01% 454
2023
Q2
$486K Sell
8,604
-4,853
-36% -$269K 0.01% 448
2023
Q1
$780K Buy
13,457
+310
+2% +$20.9K 0.01% 368
2022
Q4
$951K Buy
13,147
+170
+1% +$12.2K 0.02% 346
2022
Q3
$789K Buy
12,977
+400
+3% +$25.6K 0.02% 356
2022
Q2
$790K Sell
12,577
-211
-2% -$14K 0.02% 366
2022
Q1
$899K Sell
12,788
-85
-0.7% -$5.75K 0.02% 364
2021
Q4
$805K Sell
12,873
-556
-4% -$34.9K 0.01% 379
2021
Q3
$829K Sell
13,429
-288
-2% -$17.3K 0.01% 371
2021
Q2
$821K Buy
13,717
+433
+3% +$27.4K 0.02% 368
2021
Q1
$808K Sell
13,284
-415
-3% -$22.9K 0.02% 363
2020
Q4
$643K Sell
13,699
-1,530
-10% -$66.3K 0.01% 388
2020
Q3
$566K Buy
15,229
+748
+5% +$28.4K 0.01% 373
2020
Q2
$528K Sell
14,481
-184
-1% -$6.41K 0.01% 372
2020
Q1
$449K Sell
14,665
-249
-2% -$11K 0.01% 365
2019
Q4
$760K Sell
14,914
-1,550
-9% -$74.8K 0.02% 321
2019
Q3
$777K Buy
16,464
+2,458
+18% +$117K 0.02% 308
2019
Q2
$695K Sell
14,006
-150
-1% -$7.05K 0.02% 307
2019
Q1
$603K Sell
14,156
-102
-0.7% -$4.51K 0.02% 323
2018
Q4
$585K Buy
14,258
+508
+4% +$21.8K 0.02% 301
2018
Q3
$643K Sell
13,750
-35
-0.3% -$1.6K 0.02% 304
2018
Q2
$601K Buy
13,785
+2,188
+19% +$102K 0.02% 301
2018
Q1
$533K Buy
11,597
+500
+5% +$24.3K 0.02% 313
2017
Q4
$562K Buy
11,097
+122
+1% +$6.43K 0.02% 307
2017
Q3
$570K Sell
10,975
-2,575
-19% -$125K 0.02% 313
2017
Q2
$664K Buy
13,550
+1,772
+15% +$82.2K 0.02% 302
2017
Q1
$555K Buy
11,778
+3,721
+46% +$177K 0.02% 319
2016
Q4
$387K Buy
8,057
+462
+6% +$21.2K 0.01% 353
2016
Q3
$300K Buy
7,595
+1,241
+20% +$46.7K 0.01% 382
2016
Q2
$225K Sell
6,354
-1,037
-14% -$40.4K 0.01% 402
2016
Q1
$289K Sell
7,391
-2,884
-28% -$108K 0.01% 378
2015
Q4
$442K Buy
10,275
+1,032
+11% +$45.4K 0.02% 303
2015
Q3
$389K Sell
9,243
-34
-0.4% -$1.59K 0.02% 302
2015
Q2
$463K Hold
9,277
0.02% 266
2015
Q1
$418K Hold
9,277
0.02% 275
2014
Q4
$447K Hold
9,277
0.02% 265
2014
Q3
$444K Sell
9,277
-345
-4% -$16.8K 0.02% 248
2014
Q2
$476K Buy
9,622
+3,264
+51% +$153K 0.02% 243
2014
Q1
$299K Sell
6,358
-561
-8% -$25.8K 0.01% 276
2013
Q4
$333K Sell
6,919
-26
-0.4% -$1.17K 0.01% 250
2013
Q3
$290K Hold
6,945
0.01% 259
2013
Q2
$283K Buy
+6,945
New +$255K 0.01% 261

Other funds holding MET

Fiduciary Trust's MET Position: Q1 2026 in Review

Fiduciary Trust reduced its MetLife (MET) stake by 18% in Q1 2026, selling an estimated $69.8K and leaving 4,372 shares worth $309K. The position accounts for ﹤0.01% of the portfolio, ranked #727.

Fiduciary Trust first reported a position in MET in Q2 2013 and has held it in 52 quarters since. The position peaked at $951K in Q4 2022. 1,371 funds tracked by Wall St. Rank hold MET as of Q1 2026.

  • Fiduciary Trust held 4,372 shares of MetLife worth $309K as of Q1 2026.
  • Fiduciary Trust sold 932 MetLife shares in Q1 2026, an estimated $69.8K.
  • MetLife made up ﹤0.01% of Fiduciary Trust's portfolio in Q1 2026, its #727 holding.
  • Fiduciary Trust first reported a position in MetLife in Q2 2013 and has held it in 52 quarters since.
  • Fiduciary Trust's MetLife position peaked at $951K in Q4 2022.
  • 1,371 funds tracked by Wall St. Rank held MetLife as of Q1 2026.

Based on Fiduciary Trust's 13F filing for Q1 2026, filed 15 May 2026.